Publications
31
Citations
186
Est. group size
~9
Recurring co-author estimate
Active years
7
Publishing since 2020
Typically publishes in teams of ~5 · 38% small-team papers (≤3 authors) · across 7 venues
- SOTAGLIFLOZIN, A DUAL SGLT1/2 INHIBITOR, UNLIKE THE SELECTIVE SGLT2 INHIBITOR EMPAGLIFLOZIN, INHIBITS HUMAN PLATELET ACTIVATION AND IN VIVO THROMBUS FORMATION
Journal of the American College of Cardiology · 2025
- Anti-thrombotic Therapies: Targeting Novel Approaches to Improve the Treatment of Cardiovascular Disease
Deep Blue (University of Michigan) · 2025
- CS585, a novel prostacyclin receptor agonist, demonstrates sustained efficacy in vivo in the prevention of thrombosis
European Heart Journal · 2024
- Abstract 4137045: Sustained Anti-Thrombotic Efficacy of CS585, a Novel Prostacyclin Receptor Agonist, Demonstrates Therapeutic Potential
Circulation · 2024
- Bioactive lipid regulation of platelet function, hemostasis, and thrombosis
Pharmacology & Therapeutics · 2023
- Investigating the catalytic efficiency of C22-Fatty acids with LOX human isozymes and the platelet response of the C22-oxylipin products
Archives of Biochemistry and Biophysics · 2023
- CS014 is a novel HDAC inhibitor regulating the platelet activity, fibrinolysis and clot stability for prevention of thrombosis without increased risk of bleeding
European Heart Journal · 2022
- Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in Mice
Clinical and Applied Thrombosis/Hemostasis · 2021
- Blood×7
- European Heart Journal×4
- Journal of Thrombosis and Haemostasis×3
- Journal of the American College of Cardiology×3
- Circulation×2
- Krista Goerger
Medicine · University of Michigan
- Michael Holinstat
Medicine · University of Michigan
- Rolf P. Kreutz
Medicine · Indiana University
- Steven R. Steinhubl
Medicine · Purdue University West Lafayette
- Peter Farrehi
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile